Comerica Bank Trims Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Comerica Bank decreased its holdings in HealthEquity, Inc. (NASDAQ:HQYGet Rating) by 1.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,206 shares of the company’s stock after selling 711 shares during the period. Comerica Bank’s holdings in HealthEquity were worth $2,887,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Private Trust Co. NA purchased a new position in shares of HealthEquity during the second quarter valued at $28,000. Assetmark Inc. increased its stake in shares of HealthEquity by 387.1% during the second quarter. Assetmark Inc. now owns 755 shares of the company’s stock valued at $46,000 after buying an additional 600 shares during the period. Eagle Bay Advisors LLC increased its stake in shares of HealthEquity by 137.8% during the second quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company’s stock valued at $68,000 after buying an additional 642 shares during the period. Wipfli Financial Advisors LLC purchased a new position in shares of HealthEquity during the third quarter valued at $69,000. Finally, First Horizon Advisors Inc. increased its stake in shares of HealthEquity by 701.3% during the second quarter. First Horizon Advisors Inc. now owns 1,202 shares of the company’s stock valued at $73,000 after buying an additional 1,052 shares during the period. Hedge funds and other institutional investors own 99.54% of the company’s stock.

HealthEquity Trading Up 2.5 %

HealthEquity stock opened at $59.87 on Tuesday. The company has a quick ratio of 3.01, a current ratio of 3.01 and a debt-to-equity ratio of 0.48. HealthEquity, Inc. has a 52 week low of $47.77 and a 52 week high of $79.20. The company has a market capitalization of $5.07 billion, a price-to-earnings ratio of -85.53, a price-to-earnings-growth ratio of 3.08 and a beta of 0.80. The stock has a 50-day moving average price of $62.42 and a 200 day moving average price of $64.68.

HealthEquity (NASDAQ:HQYGet Rating) last released its earnings results on Tuesday, December 6th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. HealthEquity had a positive return on equity of 2.82% and a negative net margin of 7.07%. The firm had revenue of $216.09 million during the quarter, compared to the consensus estimate of $206.58 million. Sell-side analysts anticipate that HealthEquity, Inc. will post 0.74 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on HQY shares. StockNews.com lowered HealthEquity from a “hold” rating to a “sell” rating in a research note on Friday, January 6th. Royal Bank of Canada raised their price objective on HealthEquity from $70.00 to $75.00 in a research report on Monday, December 5th. Raymond James raised their price objective on HealthEquity from $75.00 to $85.00 and gave the company an “outperform” rating in a research report on Monday, December 12th. Jefferies Financial Group raised their price objective on HealthEquity from $80.00 to $90.00 in a research report on Wednesday, November 2nd. Finally, Wells Fargo & Company dropped their price objective on HealthEquity from $104.00 to $101.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $81.23.

Insider Buying and Selling

In related news, Director Gayle Furgurson Wellborn sold 5,237 shares of HealthEquity stock in a transaction dated Wednesday, December 14th. The stock was sold at an average price of $62.00, for a total transaction of $324,694.00. Following the completion of the sale, the director now owns 12,023 shares of the company’s stock, valued at $745,426. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Delano Ladd sold 5,897 shares of HealthEquity stock in a transaction that occurred on Friday, October 21st. The stock was sold at an average price of $75.00, for a total transaction of $442,275.00. Following the completion of the transaction, the executive vice president now directly owns 37,471 shares in the company, valued at $2,810,325. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gayle Furgurson Wellborn sold 5,237 shares of HealthEquity stock in a transaction that occurred on Wednesday, December 14th. The shares were sold at an average price of $62.00, for a total value of $324,694.00. Following the transaction, the director now owns 12,023 shares of the company’s stock, valued at $745,426. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYGet Rating).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.